1887

Abstract

SUMMARY

Preparations of bacterial transfer RNA (tRNA), give dose-dependent protection of mice against encephalomyocarditis (EMC) virus infection at up to 1 mg tRNA per mouse with maximum response when the tRNA is administered around 6 h before infection. Protection occurs with intraperitoneally and intravenously administered tRNA against infections by both these routes. In some experiments significant protection occurs by single treatments of tRNA up to 24 h after infection with virus doses of 1 × LD. Some tRNA preparations of eukaryotic origin do not give significant protection. Protection is not a feature of all species of bacterial tRNA; partially purified valine, tyrosine and phenylalanine tRNAs from are not protective. tRNA treatment does not induce circulating interferon nor does it ‘hypo-reactivate’ the protective effect of poly (I). poly (C) treatment of mice. Humoral and cell mediated immune responses do not seem to be involved in tRNA mediated protection since first, cytosine arabinoside treatment does not affect protection by tRNA; second, serum from mice treated with tRNA and an EMC vaccine does not protect other mice against infection, and third, mice that survive normally lethal infections as a result of tRNA treatment are generally just as susceptible to re-infection as previously untreated, uninfected mice. Silica treatment abolishes protection of mice by tRNA implying that macrophages are necessary. However, tRNA does not seem to act by clearance of virus particles since vaccination of mice by inactivated EMC virus is not affected by tRNA treatment. These results are considered in relation to the presence of a tRNA-like structure in EMC virus RNA and protection of mice by other single stranded polynucleotides.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-34-1-73
1977-01-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/34/1/JV034001073.html?itemId=/content/journal/jgv/10.1099/0022-1317-34-1-73&mimeType=html&fmt=ahah

References

  1. Alexander P., Evans R. 1971; Endotoxin and double stranded RNA renders macrophages cytotoxic. Nature New Biology 333:76–78
    [Google Scholar]
  2. Allison A. C. 1974; On the role of mononuclear phagocytes in immunity against viruses. Progress in Medical Virology 18:15–31
    [Google Scholar]
  3. Allison A. C., Iiarington J. S., Birbeck M. 1966; An examination of the cytotoxic effects of silica on macrophages. Journal of Experimental Medicine 124:141–154
    [Google Scholar]
  4. Beyer M. M., Friedman E. A. 1975; Prolonged survival of rabbit skin and kidney allografts following donor treatment with cytosine arabinosidc. Transplantation 19:60–63
    [Google Scholar]
  5. Bradish C. J., Allner K., Fitzgeorge R. 1975; Immunomodification and expression of virulence in mice by defined strains of Semliki Forest virus: the effects or myocrisin and L-asparaginase. Journal of General Virology 28:239–250
    [Google Scholar]
  6. Connors T. A. 1973; Cytotoxic agents with immunosuppressive activity. Biochemical Society Transactions 1:1049–1054
    [Google Scholar]
  7. De Clercq E. 1974; Synthetic interferon inducers. Topics in Current Chemistry 52:173–208
    [Google Scholar]
  8. Ebel J. P., Weil J. H., Beck G., Bollack C., Colobert L., Louisot P. 1968; Inhibition of the multiplication of Myxovirus and Arbovirus by chemically modified ribonucleic acids from the host cells. Biochemical and Biophysical Research Communications 30:148–152
    [Google Scholar]
  9. Eustatia J. M., Maase E., Van Helden P., Van Der Veen J. 1972; Viral replication in mouse macrophages. Archiv fiir die gesamte Virusforschung 39:376–380
    [Google Scholar]
  10. Ho M. 1973; Factors influencing interferon production. In Interferons and Interferon Inducers pp 73–105 Edited by Finter N. B. Amsterdam and London: North-Holland Publishing Company;
    [Google Scholar]
  11. Lindley I. J. D., Stebbing N. 1977; Aminoacylation of encephalomyocarditis virus RNA. Journal of General Virology 34:177–182
    [Google Scholar]
  12. Loening U. E. 1969; The determination of the molecular weight of ribonucleic acid by polyacrylamide-gel electrophoresis. Biochemistry Journal 113:131–138
    [Google Scholar]
  13. Mims C. A. 1964; Aspects of the pathogenesis of viral diseases. Bacteriological Reviews 28:30–71
    [Google Scholar]
  14. Nomura M., Held W. A. 1974; Reconstitution of ribosomes: studies of ribosome structure, function and assembly. In Ribosomes pp 193–223 Edited by Nomura M., Tissieres A., Lengyel P. Cold Spring Flarbor Monograph Series;
    [Google Scholar]
  15. Parish J. H., Kirby K. S. 1966; Reagents which reduce interactions between ribosomal RNA and rapidly labelled RNA from rat liver. Biochimica et Biophysica Acta 129:554–562
    [Google Scholar]
  16. Peto R., Pike M. C. 1973; Conservatism of the approximation Σ(O–E)2/E in the logrank test for survival data or tumour incidence data. Biometrics 29:579–584
    [Google Scholar]
  17. Philipps G. R. 1969; Primary structure of transfer RNA. Nature, London 333:374–377
    [Google Scholar]
  18. Salomon R., Littauer U. Z. 1974; Enzymatic acylation of histidine to mengovirus RNA. Nature, London 249:32–34
    [Google Scholar]
  19. Stebbing N., Grantham C. A., Carey N. H. 1976; Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction. Journal of General Virology 30:21–39
    [Google Scholar]
  20. Stebbing N., Grantham C. A., Kaminski F. Investigation of the antiviral mechanism of poly 1 and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice. Journal of General Virology 32:25–35
    [Google Scholar]
  21. Takano K., Warren J., Jensen K. E., Neal A. L. 1965; Nucleic acid-induced resistance to viral infection. Journal of Bacteriology go1542–1547
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-34-1-73
Loading
/content/journal/jgv/10.1099/0022-1317-34-1-73
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error